Hélène Plun‐Favreau

11.0k total citations
44 papers, 3.9k citations indexed

About

Hélène Plun‐Favreau is a scholar working on Neurology, Molecular Biology and Epidemiology. According to data from OpenAlex, Hélène Plun‐Favreau has authored 44 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Neurology, 17 papers in Molecular Biology and 16 papers in Epidemiology. Recurrent topics in Hélène Plun‐Favreau's work include Parkinson's Disease Mechanisms and Treatments (25 papers), Autophagy in Disease and Therapy (16 papers) and Mitochondrial Function and Pathology (10 papers). Hélène Plun‐Favreau is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (25 papers), Autophagy in Disease and Therapy (16 papers) and Mitochondrial Function and Pathology (10 papers). Hélène Plun‐Favreau collaborates with scholars based in United Kingdom, United States and France. Hélène Plun‐Favreau's co-authors include Nicholas Wood, Emma Deas, L. Miguel Martins, Andrey Y. Abramov, Sonia Gandhi, Julian Downward, Patrick A. Lewis, John Hardy, Victoria L. Harvey and Susanne K. Kjær and has published in prestigious journals such as Journal of Biological Chemistry, Neuron and Nature reviews. Cancer.

In The Last Decade

Hélène Plun‐Favreau

43 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hélène Plun‐Favreau United Kingdom 29 2.0k 1.6k 1.1k 814 798 44 3.9k
Charbel Moussa United States 36 1.5k 0.7× 1.5k 0.9× 793 0.7× 1.0k 1.2× 1.6k 2.0× 83 4.2k
Fabienne C. Fiesel United States 30 2.8k 1.4× 2.2k 1.3× 2.4k 2.2× 779 1.0× 963 1.2× 50 5.3k
Wolfdieter Springer United States 29 2.9k 1.4× 2.0k 1.2× 2.5k 2.2× 777 1.0× 984 1.2× 58 5.3k
Shigeto Sato Japan 30 2.8k 1.3× 2.0k 1.2× 2.6k 2.3× 846 1.0× 897 1.1× 53 5.0k
Shinsuke Ishigaki Japan 33 2.3k 1.1× 1.8k 1.1× 530 0.5× 518 0.6× 536 0.7× 75 4.4k
Jordi Magrané United States 27 2.2k 1.1× 1.4k 0.9× 1.1k 1.0× 781 1.0× 1.0k 1.3× 36 3.9k
Christine Vande Velde Canada 32 3.7k 1.8× 4.1k 2.5× 671 0.6× 925 1.1× 949 1.2× 58 7.1k
Vanessa A. Morais Portugal 27 1.7k 0.8× 762 0.5× 612 0.5× 441 0.5× 653 0.8× 56 2.8k
Kei Okatsu Japan 16 2.8k 1.4× 1.5k 0.9× 2.9k 2.6× 440 0.5× 727 0.9× 27 4.4k
Seok Min Jin United States 12 3.4k 1.6× 1.5k 0.9× 3.0k 2.6× 612 0.8× 1.1k 1.4× 12 5.3k

Countries citing papers authored by Hélène Plun‐Favreau

Since Specialization
Citations

This map shows the geographic impact of Hélène Plun‐Favreau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hélène Plun‐Favreau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hélène Plun‐Favreau more than expected).

Fields of papers citing papers by Hélène Plun‐Favreau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hélène Plun‐Favreau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hélène Plun‐Favreau. The network helps show where Hélène Plun‐Favreau may publish in the future.

Co-authorship network of co-authors of Hélène Plun‐Favreau

This figure shows the co-authorship network connecting the top 25 collaborators of Hélène Plun‐Favreau. A scholar is included among the top collaborators of Hélène Plun‐Favreau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hélène Plun‐Favreau. Hélène Plun‐Favreau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Callaghan, Benjamin, et al.. (2024). Common genetic risk for Parkinson's disease and dysfunction of the endo-lysosomal system. Philosophical Transactions of the Royal Society B Biological Sciences. 379(1899). 20220517–20220517. 6 indexed citations
2.
Reynolds, Regina H., Benjamin O’Callaghan, Sonia García-Ruiz, et al.. (2023). The non-specific lethal complex regulates genes and pathways genetically linked to Parkinson’s disease. Brain. 146(12). 4974–4987. 2 indexed citations
3.
O’Callaghan, Benjamin, John Hardy, & Hélène Plun‐Favreau. (2023). PINK1: From Parkinson’s disease to mitophagy and back again. PLoS Biology. 21(6). e3002196–e3002196. 13 indexed citations
4.
Lewis, Patrick A., et al.. (2020). Pierre D. and the First Photographs of Parkinson's Disease. Movement Disorders. 35(3). 389–391. 3 indexed citations
5.
Soutar, Marc P. M., Shuichi Miyakawa, Jasmine Harley, et al.. (2018). AKT signalling selectively regulates PINK1 mitophagy in SHSY5Y cells and human iPSC-derived neurons. Scientific Reports. 8(1). 8855–8855. 47 indexed citations
6.
Manzoni, Claudia, Adamantios Mamais, Sybille Dihanich, et al.. (2018). mTOR independent alteration in ULK1 Ser758 phosphorylation following chronic LRRK2 kinase inhibition. Bioscience Reports. 38(2). 15 indexed citations
7.
Esteras, Noemí, et al.. (2016). Deficiency of Parkinson’s disease-related gene Fbxo7 is associated with impaired mitochondrial metabolism by PARP activation. Cell Death and Differentiation. 24(1). 120–131. 53 indexed citations
8.
Manzoni, Claudia, Adamantios Mamais, Dorien A. Roosen, et al.. (2016). mTOR independent regulation of macroautophagy by Leucine Rich Repeat Kinase 2 via Beclin-1. Scientific Reports. 6(1). 35106–35106. 70 indexed citations
9.
Tufi, Roberta, Sonia Gandhi, Inês Pimenta de Castro, et al.. (2014). Enhancing nucleotide metabolism protects against mitochondrial dysfunction and neurodegeneration in a PINK1 model of Parkinson’s disease. Nature Cell Biology. 16(2). 157–166. 116 indexed citations
10.
Bartolomé, Fernando Benito, Hsiu-Chuan Wu, Victoria Burchell, et al.. (2013). Pathogenic VCP Mutations Induce Mitochondrial Uncoupling and Reduced ATP Levels. Neuron. 78(1). 57–64. 121 indexed citations
11.
Devine, Michael J., Hélène Plun‐Favreau, & Nicholas Wood. (2011). Parkinson's disease and cancer: two wars, one front. Nature reviews. Cancer. 11(11). 813–823. 130 indexed citations
12.
Deas, Emma, Hélène Plun‐Favreau, Sonia Gandhi, et al.. (2010). PINK1 cleavage at position A103 by the mitochondrial protease PARL. Human Molecular Genetics. 20(5). 867–879. 390 indexed citations
13.
Tain, Luke S., Ran Tao, Hélène Plun‐Favreau, et al.. (2009). Drosophila HtrA2 is dispensable for apoptosis but acts downstream of PINK1 independently from Parkin. Cell Death and Differentiation. 16(8). 1118–1125. 70 indexed citations
14.
Moisoi, Nicoleta, Kristina Klupsch, Valentina Fedele, et al.. (2008). Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response. Cell Death and Differentiation. 16(3). 449–464. 143 indexed citations
15.
Fitzgerald, Julia C. & Hélène Plun‐Favreau. (2008). Emerging pathways in genetic Parkinson’s disease: Autosomal‐recessive genes in Parkinson’s disease – a common pathway?. FEBS Journal. 275(23). 5758–5766. 52 indexed citations
16.
Strauss, Karsten M., L. Miguel Martins, Hélène Plun‐Favreau, et al.. (2005). Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Human Molecular Genetics. 14(15). 2099–2111. 430 indexed citations
17.
Plun‐Favreau, Hélène, David Perret, Caroline Diveu, et al.. (2003). Leukemia Inhibitory Factor (LIF), Cardiotrophin-1, and Oncostatin M Share Structural Binding Determinants in the Immunoglobulin-like Domain of LIF Receptor. Journal of Biological Chemistry. 278(29). 27169–27179. 49 indexed citations
18.
Guillet, Catherine, Eric Lelièvre, Hélène Plun‐Favreau, et al.. (2002). Functionally active fusion protein of the novel composite cytokine CLC/soluble CNTF receptor. European Journal of Biochemistry. 269(7). 1932–1941. 12 indexed citations
19.
Guillet, Catherine, Eric Lelièvre, Hélène Plun‐Favreau, et al.. (2002). Functionally active fusion protein of the novel composite cytokine CLC/soluble CNTF receptor. European Journal of Biochemistry. 269(7). 1932–1941. 1 indexed citations
20.
Lelièvre, Eric, Hélène Plun‐Favreau, Sylvie Chevalier, et al.. (2001). Signaling Pathways Recruited by the Cardiotrophin-like Cytokine/Cytokine-like Factor-1 Composite Cytokine. Journal of Biological Chemistry. 276(25). 22476–22484. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charbel Moussa Breakdown of academic impact, for papers by Fabienne C. Fiesel Breakdown of academic impact, for papers by Wolfdieter Springer Breakdown of academic impact, for papers by Shigeto Sato Breakdown of academic impact, for papers by Shinsuke Ishigaki Breakdown of academic impact, for papers by Jordi Magrané Breakdown of academic impact, for papers by Christine Vande Velde Breakdown of academic impact, for papers by Vanessa A. Morais Breakdown of academic impact, for papers by Kei Okatsu Breakdown of academic impact, for papers by Seok Min Jin
Rankless by CCL
2026